Audentes Therapeutics Inc. promoted Natalie Holles to president and COO.
Holles was senior vice president and COO.
In the new role, she will oversee the day-to-day operations of the company, including research, development, manufacturing, program management and corporate development.
Holles joined Audentes in 2015, bringing 15 years of corporate development, strategic planning and commercial experience gained in a range of therapeutic areas and with a focus on rare diseases, Audentes said in a statement.
